Articles
Haemo-Rheological Therapy Control And Monitoring By Measuring The Plasma Viscosity And Inherent Viscosity Of The Therapeutic Substance Used
November 2, 2007
Click Here To Download:
•Application Note: Haemo-Rheological Therapy Control And Monitoring By Measuring The Plasma Viscosity And Inherent Viscosity Of The Therapeutic Substance Used
•Application Note: Haemo-Rheological Therapy Control And Monitoring By Measuring The Plasma Viscosity And Inherent Viscosity Of The Therapeutic Substance Used
•Application Note: Haemo-Rheological Therapy Control And Monitoring By Measuring The Plasma Viscosity And Inherent Viscosity Of The Therapeutic Substance Used
The aim of haemodilution therapy on patients with peripheral occlusive arterial disease is the reduction of plasma viscosity (and therefore the reduction of blood viscosity). The evaluation of the plasma viscosity therefore is of great interest in haemodilution therapy.
During haemodilution therapy, the plasma viscosity is strongly affected by the viscosity of the therapeutic substance used. Therefore it is also necessary to evaluate the viscosity of this drug.
Click Here To Download:•Application Note: Haemo-Rheological Therapy Control And Monitoring By Measuring The Plasma Viscosity And Inherent Viscosity Of The Therapeutic Substance Used
